Results 111 to 120 of about 433,450 (245)
DIXDC1 drives bladder cancer progression by binding and stabilizing DLAT. This axis enhances NEK7 and CCNE2 mRNA stability to promote proliferation and lymphatic metastasis, while limiting copper‐induced DLAT oligomerization to reduce cuproptosis sensitivity, identifying DIXDC1 as a potential target linking metastasis with cuproptosis resistance ...
Hongqiong Li +17 more
wiley +1 more source
Benign Glomus Tumor of the Urinary Bladder: A Case Report and Literature Review.
Introduction: Glomus tumors (GT) are sporadic mesenchymal neoplasms found in adults, comprising less than 2% of soft tissue tumors. GT originates from glomocytes, which are modified vascular smooth muscle cells located in the walls of specialized ...
Lutfi Alia +4 more
doaj +1 more source
REPORT OF THE BLADDER TUMOR STUDY GROUP IN OSAKA (1) REGIONAL DISTRIBUTION OF PATIENTS WITH BLADDER TUMOR IN OSAKA PREFECTURE [PDF]
This is a statistical study of age and sex, chief complaints and regional distribution of 850 patients with bladder tumors who consulted the urological clinics belonging to the Bladder Tumor Study Group in Osaka during the one and a half years from ...
大阪膀胱腫瘍研究会
core
BNC2 exhibits context‐dependent opposing functions across multiple cancer types. This study reveals BNC2 as an oncogenic driver of melanoma proliferation and metastasis through transcriptional activation of PIK3CA. The natural compound TSN simultaneously degrades BNC2 and its oncogenic partner SMAD3 via CRBN‐dependent ubiquitination.
Hui Dai +7 more
wiley +1 more source
Objevtive: to assess whether microinjecting epirubicin into cells showing multidrug resistance (MDR, common to many cancers, including bladder cancer, with resistance to, e.g.
Birch, B.R +5 more
core +1 more source
AARS1 drives PI3K–AKT–mTOR‐dependent glycolysis in bladder cancer, promoting lactate accumulation, increased lactylation, H3K27la enrichment at the HK2 promoter, and HK2 transcription. HK2 reinforces glycolysis, sustaining a metabolic–epigenetic program associated with tumor progression, recurrence, and metastasis.
Qin Yuan +13 more
wiley +1 more source
CAF‐derived exosomes deliver circFAD104 into TNBC cells, where it acts as a molecular scaffold that bridges the E3 ligase MARCHF8 and PGM1, promoting MARCHF8‐mediated K48‐linked ubiquitination and proteasomal degradation of PGM1. Loss of PGM1 redirects glucose‐phosphate flux from glycogen synthesis toward glycolysis, thereby driving stemness, EMT, and ...
Lei Wang +16 more
wiley +1 more source
Tow cases were studied and followed. Both of the cases were diagnosed as having secondary metastasis of penis ( Primary cancer in urinary bladder). Both cases were operated by T.U.R technique. Both patients returned
Hooshang Bab-Al-Havaejee
doaj
Non-urothelial bladder neoplasms: small-cell neuroendocrine cancer
BACKGROUND: Neuroendocrine tumors (NET) are uncommon neoplasms. Small cell carcinoma of the bladder (SCCB) is a rare, poorly differentiated neuroendocrine tumor. It takes origin from cells of nervous and endocrine systems whitin the bladder.
Olivieri Valerio +7 more
core
TNFRSF19 is an epigenetically silenced regulator of mitophagy in triple‐negative breast cancer. TNFRSF19 deficiency activates the TGFBR1–SMAD3–PINK1 axis to promote mitophagy and confer doxorubicin resistance, whereas decitabine‐mediated restoration of TNFRSF19 suppresses mitophagy and enhances doxorubicin sensitivity, revealing a targetable epigenetic–
Shiyang Liu +7 more
wiley +1 more source

